Bone |
hADSC |
Microfibers, centrifugation |
1.2 mm2
|
2 × 104 cells/100 μL |
Calvarial bone defect (Bone regeneration: 42.48 ± 10.84%) |
VEGF |
[169] |
hADSC |
Nanofibers, centrifugation |
0.425 mm2
|
4 × 104 cells |
Calvarial bone defect(Bone regeneration: 59.97 ± 18.33%) |
Non-analysis |
[168] |
BMSC |
Ultra-Low Attachment plates |
530 μm |
1 × 104 cells |
Calvarial bone defect(Bone regeneration: 77.1 ± 4.1%) |
Non-analysis |
[170] |
BMSC |
Nonadherent microwell plates |
300 μm |
1 × 104 cells |
Segmental bone defect(Bone volume: 58 mm3) |
VEGF |
[171] |
Cartilage |
ADMSC |
Non-fouling scaffold |
80–110 μm |
5 × 107 cells/mL |
Articular cartilage defect(Collagen type II: 92%GAG: 89%) |
Non-analysis |
[175] |
hADSC |
Porous scaffold |
100–200 μm |
5 × 107 cells/mL |
Articular cartilage defect(Collagen type II: 83%GAGs: 82%) |
TGF-β1 |
[176] |
MSC |
Ultra-Low Attachment plates |
291.3 μm |
1 × 104 cells/well |
Osteochondraldefect(Cartilage tissue regeneration: 74.0 ± 5.9%) |
Non-analysis |
[178] |
ASC |
Porous scaffold |
80–110 μm |
5 × 107 cells/mL |
Osteochondraldefect(Collagen type II: 81%,GAGs: 91%) |
– |
[177] |
ADSC |
Membrane |
∼90 μm |
8 × 104 cells/well |
Articular cartilage defect(High GAG expression) |
SDF-1 |
[179] |
Nerve |
hGMSC |
Ultra-Low Attachment plates |
∼500 μm |
4 × 104 cells/well |
Facial nerve(High β-tubulin IIIand S-100 β expression) |
Non-analysis |
[188] |
ADMSC |
Sulfonated chitosan well plate |
– |
2.8 × 104 cells/cm2
|
Nerve conduits(90% differentiation into immature Schwann cells; great peak amplitude and nerve conduction velocity) |
HGF, NGF, BDNF, GDNF, and SDF-1 |
[117] |
Blood vessel |
hAMSC |
Porous hydrogel |
200–300 μm |
5 × 106 cells/mL |
Ischemic limb(Promoted angiogenesis, healthy myofiber, and regeneration of myofiber) |
VEGF and IGF-1 |
[192] |
hAMSC |
Porous scaffold |
220 μm |
5 × 107 cells/mL |
Subcutaneous vascular ingrowth, and adipose tissue regeneration |
VEGF and FGF-2 |
[190] |
Tooth |
hDPSC |
Agarose microwell |
∼300 μm |
2.6 × 105 cells/190 μL |
Regenerated and vascularized dental pulp-like tissue |
Non-analysis |
[194] |
hDPSC |
Ultra-Low Attachment plates |
∼60 μm |
3.3 × 105 cells in 3 mL of pellet |
Regenerative dentin and neurovascular-like structures that mimicked the native teeth |
VEGF and TGF-β |
[195] |
Skin |
hADSC |
Hanging drop |
200–300 μm |
8000−10000 cells/25 μL |
Skin wounds(Wound regeneration: 100%epithelium thickness: 150 μmcollagen density: 40%CD31 expression: 35%) |
IL-10 and TGF-β1 |
[200] |
hADSC |
Ultra-Low Attachment plates |
1.2–1.5 mm |
7.5 × 104 cells/cm2
|
Skin wounds(Rapid wound closure andhigher histological score) |
VEGF, FGF, and HGF |
[199] |
Human placenta-derived MSCs |
Hanging drop |
100 μm |
5000 cells/droplet |
Skin wound(Fast wound reepithelization and closure,enhanced microvessel density, andhigher expression of paracrine factors) |
VEGFa, SDF-1, and Ang1 |
[197] |
Heart |
hBMSC |
Hanging drop |
260 μm |
3 × 105 cells |
Myocardial infarction(Enhanced vascularization, enhanced Cx43 expression, and improved cardiac function |
VEGF, FGF, and HGF |
[250] |
Human cardiac stem cell |
Ultra-Low Attachment plates |
95 μm |
5 × 105
|
Myocardial infarction(Enhanced neovascularization, decreased fibrotic area, increased left ventricle thickness, and improved cardiac function) |
FGF1, FGF2, FGF4, FGF5, FGF7, FGF16, IGF1, NGFβ, NRG4, ZEP91, ANGPT4, EFNA1, EFNA5, EFNB3, PDGFC, VEGFC, GH1, IFNA1, and IFNE1 |
[112] |
Human cardiac stem cell |
6-well tissue culture plates coated with poly-2-hydroxyethyl methacrylate |
75 μm |
1052 cells |
Myocardial infarction(Improved cardiac function and decreased fibrotic area) |
SDF-1α and MCP-1 |
[201] |
Kidney |
hMSC |
Ultra-Low Attachment plates |
241 μm |
1500 cells |
Hypertensive kidney disease(Reduced proteinuria, improved glomerular permselective function) |
VEGFA, HGF, IGF, and SDF-1 |
[204] |
hADMSC |
Hanging drop |
200 μm |
25,000 cells |
Ischemic kidney(Decreased creatinine and BUN levels, reduced tissue apoptosis and damage, and enhanced vascularization) |
VEGF, EGF, IGF, bFGF, HGF, and TSG-6 |
[113] |
Liver |
hADMSC |
Hanging drop |
500 μm |
1 × 106 cells |
Hepatic fibrosis(Reduced hepatic fibrosis, decreased collagen I and collagen III expression, and improved liver function |
IGF-1, HGF, and IL-6 |
[114] |
Human teeth-derived Stem cells |
Ultra-Low Attachment plates |
– |
1 × 105 cells |
Hepatic fibrosis(Reduced hepatic fibrosis and reduced bleeding) |
TGF-β1 |
[206] |
human umbilical cord-derived -MSC |
Rocker system |
111 μm |
1 × 106 cells |
Acute liver failure(Activated liver regeneration, reduced necrosis, and improved regeneration of hepatocytes |
IFN-γ, IL-6, and TNF-α |
[251] |
Lung |
hADMSC |
PDMS-based microwell |
150 μm |
1 × 105 cells |
Emphysema(Recovered alveolar damage and enhanced growth factor production) |
FGF-2, VEGF, and HGF |
[115] |